oculis pharma

Oculis raises an additional $15M in funding before going public

Oculis raises an additional $15M in funding before going public

The Iceland-founded biopharmaceutical company Oculis which is purposefully driven to save sight and improve eye care with innovations has raised $15M as first reported by Viðskiptablaðið. The participating investors in this newly secured funding round are from Iceland and abroad. This funding adds to the $80M that the company raised

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Iceland founded Oculis Pharma has closed an oversubscribed $57 million Series C financing. Oculis said in a press release that the proceeds from the financing will accelerate the company’s strategy with the aim of delivering key goals in the near future to drive shareholder value and bring transformative therapies

Oculis Pharma raises Series A led by Brunnur Ventures and Silfurberg

The pharmaceutical startup Oculis Pharma announced a Series A financing led by investors Brunnur Ventures and Silfurberg. The amount is undisclosed. “We are delighted to receive this support from Brunnur Ventures, Silfurberg and their co-investors to progress our development of DexNP,” Páll Ragnar Jóhannesson, CEO of Oculis, said in a